InspireMD, Inc.
General ticker "NSPR" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $160.0M (TTM average)
InspireMD, Inc. does not follow the US Stock Market performance with the rate: -28.8%.
Estimated limits based on current volatility of 4.4%: low 0.94$, high 1.03$
Factors to consider:
- Total employees count: 67 (+1.5%) as of 2024
- Top business risk factors: Liquidity and credit risks, Capital raising, Intellectual property risks, Regulatory and compliance, Manufacturing risks
Short-term NSPR quotes
Long-term NSPR plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $6.21MM | $7.01MM | $8.98MM |
| Operating Expenses | $27.35MM | $40.51MM | $58.59MM |
| Operating Income | $-21.14MM | $-33.50MM | $-49.61MM |
| Non-Operating Income | $1.29MM | $1.56MM | $0.89MM |
| R&D Expense | $7.98MM | $13.63MM | $15.00MM |
| Income(Loss) | $-19.85MM | $-31.95MM | $-48.72MM |
| Taxes | $0.07MM | $0.06MM | $0.06MM |
| Net Income(Loss)* | $-19.92MM | $-32.01MM | $-48.79MM |
| Stockholders Equity | $39.50MM | $36.09MM | $55.20MM |
| Inventory | $2.11MM | $2.57MM | $3.40MM |
| Assets | $47.64MM | $46.81MM | $69.40MM |
| Operating Cash Flow | $-16.38MM | $-21.87MM | $-35.10MM |
| Capital expenditure | $0.38MM | $1.40MM | $1.66MM |
| Investing Cash Flow | $-16.09MM | $12.64MM | $-30.56MM |
| Financing Cash Flow | $37.53MM | $18.45MM | $55.57MM |
| Earnings Per Share** | $-0.82 | $-0.76 | $-0.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.